Low-density lipoprotein susceptibility to oxidation and cytotoxicity to endothelium in sickle cell anemia

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 6, 1999, Pages 605-612

  Belcher, J D ^a   Marker, P H ^b   Geiger, P ^b   Girotti, A W ^b   Steinberg, M H ^b   Hebbel, R P ^b   Vercellotti, G M ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033153333     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90191-9     Document Type: Article

References (56)

1. 1. Klug PP, Kaye N, Jensen WN. Endothelial cell and vascular damage in the sickle cell disorders. Blood Cells 1982;8:175-84.
2. 2. Sowemimo-Coker SU, Meiselman HJ, Francis RB Jr. Increased circulating endothelial cells in sickle cell crisis. Am J Hematol 1989;31:263-5.
3. 3. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 1997;337:1584-90.
4. 4. Hebbel RP, Eaton JW, Balasingam M, Steinberg MH. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest 1982;70:1253-9.
5. 5. Dias-Da-Motta P, Arruda VR, Muscarra MN, Saad ST, De Nucci G, Costa FF, et al. The release of nitric oxide and Superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia. Br J Haemotol 1996;93:333-40.
6. 6. Asakura T, Minakala K, Adachi K, Russell MO, Schwartz E. Denatured hemoglobin in sickle erythrocytes. J Clin Invest 1977;59:633-40.
7. 7. Kuross SA, Hebbel RP. Nonheme iron in sickle erythrocyte membranes: association with phospholipids and potential role in lipid peroxidation. Blood 1988;72:1278-85.
8. 8. Zerez CR, Tanaka KR. Erythrocyte metabolism. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, editors. Sickle cell disease: basic principles and clinical practice. New York (NY): Raven Press, Ltd; 1994. p. 153-61.
9. 9. Natta C, Machlin L, Plasma levels of tocopherol in sickle cell anemia subjects. Am J Clin Nutr 1979;32:1359-62.
10. 10. Heinecke JW, Baker L, Rosen L, Chait A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest 1986;77:757-61.
11. 11. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by the receptor for acetylated low density lipoproteins. Proc Natl Acad Sci U S A 1983;78:6499-503.
12. 12. Balla G, Jacob HS, Eaton JW, Belcher JD, Vercellotti GM. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury, Arterioscler Thromb 1991;11:1700-11.
13. 13. Miller YI, Felikman Y, Shaklai N. Hemoglobin induced apolipoprotein B crosslinking in low-density lipoprotein peroxidation. Arch Biochem Biophys 1996;326:252-60.
14. 14. Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G, Jurgens G. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol 1990;3:77-92.
15. 15. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997;272:20963-6.
16. 16. Exner M, Susani M, Witztum JL, Hovorka A, Curtiss LK, Spitzauer S, et al. Lipoproteins accumulate in immune deposits and are modified by lipid peroxidation in passive Heymann nephritis. Am J Pathol 1996;149:1313-20.
17. 17. Belcher JD, Balla J, Balla G, Jacobs DR Jr, Gross M, Jacob HS, et al. Vitamin E, LDL, and endothelium: brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler Thromb 1993;13:1779-89.
18. 18. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
19. 19. Forti RL, Schuffman SS, Davies HA, Mitchell WM. Objective antiviral assay of the interferons by computer assisted data collection and analysis. Methods Enzymol 1986;119:533-40.
20. 20. Kaplan LA, Miller JA, Stein RA. Simultaneous measurement of serum retinol, tocopherols, carotenes, and carotenoids by high performance liquid chromatography. J Clin Lab Anal 1987; 1:147-52.
21. 21. Girotti AW, Thomas JP, Jordan JE. Lipid photooxidation in erythrocyte ghosts: sensitization of the membranes toward ascorbate-and superoxide-induced peroxidation and lysis. Arch Biochem Biophys 1985;236:238-51.
22. 2+-stimulated oxidation of low density lipoprotein. Arch Biochem Biophys 1994;315:244-54.
23. 23. Korytowski W, Bachowski GJ, Girotti AW. Analysis of cholesterol and phospholipid hydroperoxides by high-performance liquid chromatography with mercury cathode electrochemical detection. Anal Biochem 1993;213:111-9.
24. 24. Korytowski W, Geiger PG, Girotti AW. High-performance liquid chromatography with mercury cathode electrochemical detection: application to lipid hydroperoxide analysis. J Chromatogr B Biomed Appl 1995;670:189-97.
25. 25. Harats D, Ben-Naim M, Dabach Y, Hollander G, Stein O, Stein Y. Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis 1989;79:245-52.
26. 26. Parthasarathy S, Khoo JC, Miller E, Barnett J, Witztum JL, Steinberg D. Low density lipoprotein rich in olcic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci U S A 1990;87:3894-8.
27. 27. Stone WL, Payne PH, Adebonojo FO. Plasma-vitamin E and low plasma lipoprotein levels in sickle cell anemia patients. J Assoc Acad Minor Phys 1990;1:12-6.
28. 28. Diceber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H. Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 1991;32:1325-32.
29. 29. Princen HMG, van Poppel G, Vogelezang C, Buytenhek R, Kok FJ. Supplementation with vitamin E but not β-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro: effect of cigarette smoking, Arterioscler Thromb 1992;12:554-62.
30. 30. Jessup W, Rankin SM, De Whalley CV, Hoult JRS, Scott J, Leake DS. Alpha-tocopherol consumption during low-density-lipoprotein oxidation. Biochem J 1990;265:399-405.
31. 31. Babiy AV, Gebicki JM, Sullivan DR. Vitamin E content and low density lipoprotein oxidizability induced by free radicals. Atherosclerosis 1990;81:175-82.
32. 32. Tesoriere L, D'Arpa D, Maggio A, Giaccone V, Pedone E, Livrea MA. Oxidation resistance of LDL is correlated with vitamin E status in β-thalassemia intermedia. Atherosclerosis 1998:137:429-35.
33. 33. Krauss JS, Freant LJ, Lee JR. Gastrointestinal pathology in sickle cell disease, Ann Clin Lab Sci 1998;28:19-23.
34. 34. Livrea MA, Tesoriere L, Maggio A, D'Arpa D, Pintaudi AM, Pedone E. Oxidative modification of low-density lipoprotein and atherogenetic risk in β-thalassemia. Blood 1998;92:3936-42.
35. 35. Smith A, Morgan WT. Hemopexin-mediated heme transport to the liver: evidence for a heme-binding protein in liver plasma membranes. J Biol Chem 1985;260:8325-9.
36. 36. Camejo G, Halberg C, Manschik-Lundin A, Hurt-Camejo E, Rosengren B, Olsson H, et al. Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages. J Lipid Res 1998;39:755-66.
37. 37. Terao J. Reactions of lipid hydroperoxides. In: Vigo-Pelfrey C, editor. Membrane lipid oxidation. Vol 1. Boca Raton (FL): CRC Press; 1990. p. 219-38.
38. 38. Kenar JA, Havrilla CM, Porter NA, Guyton JR, Brown SA, Klemp KF, et al. Identification and quantification of the regioisomeric cholesteryl linoleate hydroperoxides in oxidized human low density lipoprotein and high density lipoprotein. Chem Res Toxicol 1996;9:737-44.
39. 39. van Berkel TJ, de Rijke YB, Kruijt JK. Different fate in vivo of oxidatively modified low density liporpotein and acetylated low density lipoprotein in rats: recognition by various scavenger receptors on Kupffer and endothelial liver cells. J Biol Chem 1991;266:2282-9.
40. 40. Akinyanju PA, Akinyanju CO. Plasma and red cell lipids in sickle cell disease. Ann Clin Lab Sci 1976;6:521-4.
41. 41. Saha N, Samuel AP. Sickle cell gene and liver functions in a Sudanese population. Acta Haematol 1982;68:65-7.
42. 42. Sasake J, Waterman MR, Buchanan GR, Cottam GL. Plasma and erythrocyte lipids in sickle cell anaemia. Clin Lab Haematol 1983;5:35-44,
43. 43. Muskiet FD, Muskiet FA. Lipids, fatty acids and trace elements in plasma and erythrocytes of pediatric patients with homozygous sickle cell disease. Clin Chim Acta 1984;142:1-10.
44. 44. Goldfarb AW, Rachmilewitz EA., Eisenberg S. Abnormal low and high density lipoproteins in homozygous beta-thalalassaemia. Br J Haematol 1991;79:481-6.
45. 45. el-Hazmi MA, Warsy AS, al-Swailem A, al-Swailem A, Bahakim H. Red cell genetic disorders and plasma lipids. J Trop Pediatr 1995;41:202-5.
46. 46. Monnet D, Kane F, Konan-Waidhet D, Diafouka F, Sangare A, Yapo AE. Lipid, apolipoprotein AI and B levels in Ivorian patients with sickle cell anaemia. Ann Biol Clin (Paris) 1996;54:285-8.
47. 47. Rifkind B, Gale M. Hypolipidemia in anemia. Am Heart J 1968;76:849-50.
48. 48. Morel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984;4:357-64.
49. 49. Hennig B, Chow CK. Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Radic Biol Med 1988;4:99-105.
50. 50. Tuomainen TP, Punnonen K, Nyyssonen K, Salonen JT. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 1998;97:1461-6.
51. 51. Sullivan JL, Iron and sex difference in heart disease. Lancet 1981;1:1293-4.
52. 52. Sullivan JL. The iron paradigm of ischemic heart disease. Am Heart J 1989;117:1177-88.
53. 53. Kiechi S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997;96:3300-7.
54. 54. Martin CR, Johnson CS, Cobb C, Tatter D, Haywood LJ. Myocardial infarction in sickle cell disease. J Natl Med Assoc 1996;88:428-32.
55. 55. Ohene-Frempong K, Welner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-94.
56. 56. Hebbel RP, Vercellotti GM. The endothelial biology of sickle cell disease. J Lab Clin Med 1997;129:288-93.